Research in rats suggests eating blueberries could
help regulate genetic and biochemical drivers of depression and suicide
Newswise, April 7, 2016– For many people suffering
from post-traumatic stress disorder (PTSD), available medical treatments offer
only limited relief. In a series of studies conducted in rats, researchers have
found that eating blueberries could help to reduce the genetic and biochemical
drivers behind depression and suicidal tendencies associated with the disorder.
“We need to conduct a clinical trial in people to be
certain that this works, but based on our studies in animal models, there is
evidence that blueberries may help to mitigate some of the problems associated
with PTSD,” said Joseph Francis, Ph.D., the Everett D. Besch Professor of
Veterinary Medicine at Louisiana State University’s School of Veterinary
Medicine and the study’s senior author.
“And in the meantime, it seems safe to say that
eating blueberries can’t hurt—and may help—in people with PTSD.”
Philip Ebenezer, Ph.D., a postdoctoral researcher in
Francis’s laboratory at Louisiana State University, will present this research
at the American Society for Pharmacology and Experimental Therapeutics Annual
Meeting during Experimental Biology 2016.
PTSD, an anxiety disorder that can develop after
someone experiences a traumatic event, affects an estimated 6.8 percent of
Americans at some point in their lifetimes.
PTSD diagnoses
have risen sharply in recent years and the disorder is particularly common
among combat veterans. It is associated with a wide range of psychological,
behavioral and social problems such as depression, substance abuse,
relationship problems and an increased risk of suicide.
To investigate the biological factors that might
contribute to PTSD and its effects, the research team developed a process that
induces effects analogous to PTSD in rats, such as exhibiting fear instead of
curiosity when presented with an unfamiliar object. They then assessed how
eating a diet rich in blueberries affects those factors.
In the new study, the team focused on the role of a
gene called SKA2, a gene that other researchers have found is expressed at
abnormally low levels in people who have committed suicide.
Although it is impossible to know whether a rat is
experiencing suicidal thoughts, Francis and Ebenezer found that rats with
PTSD-like effects express SKA2 at low levels compared with normal laboratory
rats, bolstering the evidence for the role of SKA2 in psychological problems
and suggesting the team’s PTSD-like rats can be a useful model for studying the
biochemistry behind suicidal tendencies.
The researchers then fed some of the PTSD-like rats
a diet rich in blueberries—the equivalent of about two cups per day for a
person—and found that SKA2 levels increased compared with rats fed a normal
diet, suggesting the blueberries had a beneficial effect.
“In the PTSD animals, there was a decrease in the
SKA2 levels in the blood, as well as in the brain’s prefrontal cortex and
hippocampus, compared to non-PTSD rats,” said Francis. “Since these levels
increased when we fed them blueberries, the findings suggest that a
nonpharmacological agent like blueberries can have an effect on the expression
of this important gene.”
The work builds on a study released last year, in
which Francis and Ebenezer found that rats with the PTSD-like experience fed a
blueberry-enriched diet showed increased levels of the signaling chemical serotonin
in the brain.
Since serotonin is associated with feelings of
happiness and well-being, that study suggested blueberries might help to
alleviate depression in patients with PTSD.
The team is now pursuing research into the links
between SKA2 and serotonin levels to find out whether blueberries may
simultaneously help relieve feelings of depression and reduce suicidal
tendencies through a single biological pathway.
There are a number of medications that increase
serotonin levels and are used to treat depression. However, these agents,
called selective serotonin reuptake inhibitors, or SSRIs, have shown limited
success in treating patients with PTSD, and have even been linked with
increased suicidal tendencies in some patients, particularly children and adolescents.
Francis said the team’s research aims to fill the
treatment gap for PTSD sufferers who do not benefit from existing medications.
“There is an urgent need to identify novel targets
for treating PTSD. Based on our findings, blueberries can not only increase
serotonin, but also increase SKA2 levels, thereby potentially protecting
against untoward behavior,” said Francis.
The study was funded by the U.S. Highbush Blueberry Council.
About
Experimental Biology 2016
Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from six sponsoring societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research. www.experimentalbiology.org
Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from six sponsoring societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research. www.experimentalbiology.org
About
the American Society for Pharmacology and Experimental Therapeutics (ASPET)
ASPET is a 5,100 member scientific society whose members conduct basic and clinical pharmacological research within the academic, industrial and government sectors. Our members discover and develop new medicines and therapeutic agents that fight existing and emerging diseases, as well as increase our knowledge regarding how therapeutics affects humans. www.aspet.org
ASPET is a 5,100 member scientific society whose members conduct basic and clinical pharmacological research within the academic, industrial and government sectors. Our members discover and develop new medicines and therapeutic agents that fight existing and emerging diseases, as well as increase our knowledge regarding how therapeutics affects humans. www.aspet.org
No comments:
Post a Comment